The global market for research antibodies is expected to reach $3 billion in 2019. Selecting the right antibody that works for your specific assay is a daunting process that is often fraught with failure. For the successful use of an antibody on any platform, the method of antibody generation is an important consideration. With multiple variables influencing antibody performance, validation of each reagent for a given application is essential. Antibodies are the foundation of traditional immunoassays such as ELISAs and Western Blots, but these formats lack throughput.
Click Image to Download the White Paper
In contrast, Luminex’s xMAP® Technology provides flexible immunoassay formats that support:
- Capture sandwich
- Competitive
- Indirect serological multiplex assays
- Protein interaction assays
xMAP-based assays can enable the testing of up to 500 analytes in a single sample reaction.